BBIO vs NAMS

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 11, 2026

BBIO

32.9
AI Score
VS
NAMS Wins

NAMS

43.9
AI Score

Investment Advisor Scores

BBIO

33score
Recommendation
SELL

NAMS

44score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric BBIO NAMS Winner
Revenue 791.36M 25.91M BBIO
Net Income -372.97M -129.97M NAMS
Net Margin -47.1% -501.7% BBIO
Operating Income -224.67M -167.47M NAMS
ROE 22.4% -20.6% BBIO
ROA -17.3% -18.9% BBIO
Total Assets 2.16B 687.99M BBIO
Cash 1.53B 423.13M BBIO
Current Ratio 2.09 11.76 NAMS

Relative Price Performance (Last 90 Days)

BBIO 1M: +25.7% · 3M: -2.1% NAMS 1M: +2.6% · 3M: -22.3%

Current Technical Phase

BBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 70

RSI (14): 69.6 · Price: $79.54

NAMS

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 50

RSI (14): 50.4 · Price: $20.72

Fundamentals Snapshot

Metric BBIO NAMS
Market Cap — —
Forward P/E -291.0 -11.4
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 1.9% 54.1%
Gross Margin 0.9% 1.0%
Operating Margin 0.0% -2.3%
EPS -3.03 -1.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, NAMS is currently the stronger investment candidate, winning 3 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.